hormone replacement

estrogen + dong quai

Dong quai (Angelica sinensis) shows estrogen-agonist activity in vitro and promotes growth of estrogen receptor-positive breast cancer cells. Combining it with prescribed estrogen therapy may add unwanted estrogenic stimulation, and dong quai's coumarin content increases bleeding risk in patients also on hormone therapy with VTE risk.